Phase 1/2 study of ixazomib with cyclophosphamide and dexamethasone in newly diagnosed AL amyloidosis

Detalles Bibliográficos
Autores principales: Rosenbaum, Cara A., Özbek, Umut, Sanchez, Larysa, Lagdameo, Jonathan, Abrahams, Alex, Hassoun, Hani, Lahoud, Oscar, Niesvizky, Ruben, Landau, Heather J., Osman, Keren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631711/
https://www.ncbi.nlm.nih.gov/pubmed/35858371
http://dx.doi.org/10.1182/bloodadvances.2022007826

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631711/
https://www.ncbi.nlm.nih.gov/pubmed/35858371
http://dx.doi.org/10.1182/bloodadvances.2022007826

Ejemplares similares